A key component of the business strategy is the in vitro diagnostics (IVD) quality control market research report. This report contains important information that helps to determine market needs and desires, market size and competition from the IVD quality control industry. It helps address a number of business challenges when the report goes hand in hand with the right tools and technology. This report focuses on in vitro diagnostics (IVD) quality control volume and value at global level, regional level and company level. It helps businesses take decisive action to address niche market threats.
Get Free Sample of This Research Report: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-in-vitro-diagnostics-ivd-quality-control-market
Global in vitro diagnostics (IVD) quality control market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. The Global Market is expected to reach USD 98.22 billion by 2025, from USD 64.0 billion in 2017 growing at a CAGR of 5.5% during the forecast period of 2018 to 2025. Some of the major players operating in global in vitro diagnostics (ivd) quality control market are
Thermo Fisher Scientific
Johnson & Johnson (US)
Dickinson and Company (US)
Sysmex Corporation (Japan)
Ortho Clinical Diagnostics (US),
Agilent Technologies (US)
Randox Laboratories Ltd. (U.K.)
Illumina, Inc. (US)
Laboratory Corporation (US)
Luminex Corporation (US)
Quest Diagnostics Incorporated (US)
SeraCare Life Sciences, Inc. (US)
Technopath Clinical Diagnostics (Ireland)
Helena Laboratories Corporation (US)
Sun Diagnostics, LLC (US)
The global in vitro diagnostics (ivd) quality control market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of in vitro diagnostics (ivd) quality control market for global, Europe, North America, Asia Pacific and South America.
In-vitro diagnostics (IVDs) are the medical devices and accessories are used to perform in-vitro tests on bodily samples such as blood, urine or tissue. In-vitro diagnostics are used for examination, diagnosis, cure and determination of the health state of several medical conditions such as Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing/Pharmacogenomics, HIV/Aids. Increasing disposable income, technically advanced diagnostic devices, rising rate of obese and diabetic population is expected to fuel the market of in-vitro diagnostics (IVDs). Whereas lack of proper reimbursement policy system rounds the globe is one among the main restraining issue for the in-vitro diagnostics market.
- According to European IVD market statistics 2014 overall revenues across EU-27 plus EFTA increased by 0.8% to €10,635 million however, this remains under the revenues recorded in 2009 (€10,685).
- As per Germany Trade & Invest (GTAI) Germany is the largest market in Europe, the new regulation is having a huge impact on in-vitro diagnostics market.
- February 2015: Roche acquired Flatiron Health to accelerate industry-wide development and delivery of breakthrough medicines for patients with cancer.
- In January 2017, Abbott acquired Alere, Inc. for company growth.
Get TOC For Full Analysis Of Report: https://databridgemarketresearch.com/toc/?dbmr=global-in-vitro-diagnostics-ivd-quality-control-market
Major Market Drivers and Restraints:
- Rising Geriatric Population and Subsequent Growth in the Prevalence of Chronic and Infectious Diseases
- Increasing Adoption of Fully Automated Instruments and Automation in Laboratories
- Growing Awareness on Personalized Medicine
- Increasing Adoption
- Unfavourable Reimbursement Scenario
Market Segmentation: Global In Vitro Diagnostics (IVD) Quality Control Market
The global in vitro diagnostics (ivd) quality control market is segmented based on
- Product & Service
- End User
- Geographical Segments
Based on product & service, the market is segmented into
- Reagents & kits
- Data management software
Based on technology, the market is segmented into
- Clinical chemistry
- Molecular diagnostics
- Coagulation and hemostasis
- Other IVD technologies
Based on application, the market is segmented into
- Infectious diseases
- Autoimmune diseases
- Drug testing/pharmacogenomics
- Hiv/aids and other applications
Based on end user, the market is segmented into
- Point-of-care testing
- Patient self-testing
- Academic institutes
- End users
The market report covers data points for 28 countries across multiple geographies namely
- North America & South America
- Middle East & Africa
Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others
Want Full Report? Enquire Here: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-in-vitro-diagnostics-ivd-quality-control-market
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing firstname.lastname@example.org . We are content with our glorious 99.9 % client satisfying rate.